כנס במדעי המוח: New therapeutic strategies in Huntington’s disease

The Adams Super Center for Brain Studies cordially invites you to a mini symposium on

New therapeutic strategies in Huntington’s disease

Chairs:

Illana Gozes
Director, The Adams Super Center for Brain Studies, Dept. of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University

Dani Offen
Felsenstein Medical Research Center, Dept. of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University

14:30

Dagmar E. Ehrnhoefer

Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver,  Canada

Caspase-6 as a therapeutic target in Huntington's disease 
 

15:00

Israel Aharony

Felsenstein Medical Research Center, Dept. of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University

A Huntingtin based peptide inhibitor of Caspase-6 provides protection against mutant Huntingtin toxicity
 

15:30

Amber Southwell‏ 

Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada

Antisense oligonucleotide gene silencing drugs for Huntington’s disease